The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Travel, Accommodations, Expenses - Celgene
Combined use of albumin and neutrophil-to-lymphocyte ratio as new prognostic and predictive factor in patients with poorly differentiated neuroendocrine carcinomas.
 
Elena Colombo
No Relationships to Disclose
 
Paolo Manca
Patents, Royalties, Other Intellectual Property - I have a patent for a method for the identification of gene panels optimal for TMB estimation (Inst)
 
Marta Bini
No Relationships to Disclose
 
Achille Bottiglieri
No Relationships to Disclose
 
Giacomo Massa
No Relationships to Disclose
 
Natalie Prinzi
Travel, Accommodations, Expenses - Ipsen; Novartis
 
Martina Torchio
Travel, Accommodations, Expenses - Ipsen; Novartis
 
Monica Niger
No Relationships to Disclose
 
Francesca Corti
No Relationships to Disclose
 
Michele Prisciandaro
No Relationships to Disclose
 
Emma Zattarin
No Relationships to Disclose
 
Claudia Proto
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Roche
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Marina Chiara Garassino
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline; MSD Oncology; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Incyte; Inivata; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi; Seagen; Takeda; Tiziana Life Sciences
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Celgene; Incyte; Lilly; MSD Oncology; Otsuka; Roche; Takeda
Research Funding - AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Blueprint Medicines; Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Spectrum Pharmaceuticals (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Massimo Milione
No Relationships to Disclose
 
Laura Cattaneo
No Relationships to Disclose
 
Maria Di Bartolomeo
Honoraria - Lilly; MSD Oncology; SERVIER
Consulting or Advisory Role - Lilly; MSD Oncology
Research Funding - Lilly
Travel, Accommodations, Expenses - Roche; Sanofi
 
Marco Platania
No Relationships to Disclose
 
Filippo G. De Braud
Honoraria - Bristol-Myers Squibb; Merck; MSD; Pfizer; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Bristol-Myers Squibb; EMD SERONO; Ignyta; Incyte; Nerviano Medical Sciences; Octimet; Pierre Fabre; Roche; Sanofi; Teofarma
Speakers' Bureau - Menarini
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Lilly (Inst); Loxo (Inst); MedImmune (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); MSD (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Philogen (Inst); Roche (Inst); SERVIER (Inst); Tesaro (Inst)
 
Giuseppe Lo Russo
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Lilly; MSD
 
Sara Pusceddu
Consulting or Advisory Role - Ipsen; Italfarmaco; Novartis; Pfizer
Research Funding - Novartis; Pfizer/Ipsen